Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

An Update from the RheumPAC Chair on the 117th Congress

Howard Blumstein, MD  |  Issue: October 2022  |  September 3, 2022

  • Growing the medical workforce by: 
    • Repealing the cap on Medicare-funded residency slots;
    • Transferring more than 30,000 Congressionally approved J1 visas to medical professionals; and
    • Deferring interest on medical student loans while in residency;
  • Mitigating step therapy protocols;
  • Banning copay accumulator policies;
  • Expanding the use of telehealth by making many of the rules instituted during the pandemic permanent;
  • Investigating pharmacy benefit manager practices to address their role in the rising cost of drugs; and
  • Increasing NIH, NIAMS and CDC research funding for rheumatic diseases, as well as securing dedicated funding for arthritis through the Department of Defense.

As you can see, it has been a busy year in Congress and of advocating for policies that can positively address the issues that impact rheumatology care providers and their patients. We only expect that to heat up towards the end of the election cycle and in the “lame duck” session of Congress.

Let us work on your behalf and give us the resources to increase the ACR’s impact on decisions in Washington, D.C. Make your investment today at www.rheumpac.org.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Howard Blumstein, MD, is a rheumatologist at Rheumatology Associates of Long Island and chair of RheumPAC.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:ACR advocacyCongressional outreachLegislationRheumPAC

Related Articles

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences